• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Number of highest risk domestic inspections in the month resulting in a classification of No Action Indicated (NAI)

Dictionary: The number of high-risk product inspections where no objectionable conditions or practices were found during the inspection (or the significance of the documented objectionable conditions found does not justify further FDA action) are classified as No Action Indicated.

Fiscal Year - 2011

Skip graphic and jump to text data

TimeTargetNumber Classified as NAI
Oct 2010N/A475
Nov 2010N/A583
Dec 2010N/A624
Jan 2011N/A526
Feb 2011N/A489
Mar 2011N/A713
Apr 2011N/A483
May 2011N/A556
Jun 2011N/A650
Jul 2011N/A364
Aug 2011N/A518
Sep 2011N/A373

FY 2011 Overall: 6,354

Percent of highest risk domestic inspections in the month resulting in a classification of No Action Indicated

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetPercent Classified as NAI
Oct 2010N/A51
Nov 2010N/A51
Dec 2010N/A55
Jan 2011N/A58
Feb 2011N/A53
Mar 2011N/A53
Apr 2011N/A51
May 2011N/A51
Jun 2011N/A54
Jul 2011N/A49
Aug 2011N/A52
Sep 2011N/A48

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.